AstraZeneca

AstraZeneca articles from Informachine.

AstraZeneca in $6.9 bn deal with Daiichi Sankyo for cancer drug development

29 Mar 2019

AstraZeneca’s Imfinzi gets Breakthrough Therapy Designation from FDA

31 Jul 2017

AstraZeneca and Merck in $8.5-billion oncology deal

27 Jul 2017

AstraZeneca licenses cancer drug Zoladex to TerSera Therapeutics

21 Feb 2017

AstraZeneca to cut 700 positions

09 Dec 2016

AstraZeneca inks $1bn plus drug development deal with Bicycle Therapeutics

02 Dec 2016

Pfizer to acquire part of AstraZeneca's antibiotics business

24 Aug 2016

AstraZeneca's bid to save Crestor sales fails, court turns down IPR protection request till 2026

21 Jul 2016

AstraZeneca’s last-ditch attempt to protect its statin Crestor failed as a federal judge denied its bid for a restraining order against Indian generic drugmakers

FluMist failed to protect kids and adults against flu

23 Jun 2016

Aspen Pharmacare to buy AstraZeneca’s anaesthetics portfolio for at least $520 mn

09 Jun 2016

Stay ahead with Informachine News Trackers! Follow your selected sources, track business news with relevant keywords, and organize seamlessly using labels and bookmarks.

Get the business updates you need, fast, focused, and tailored just for you. Save time, stay informed, and never miss a beat!

Start your free subscription today!

Latest articles on AstraZeneca from Informachine

AstraZeneca and Daiichi Sankyo announce clinical collaboration with Summit Therapeutics to evaluate Datroway in combination with ivonescimab across multiple tumour types

02 Oct 2026

AstraZeneca announces strategic equity investment and clinical collaboration with Summit Therapeutics to advance leading ADC combination strategy in cancer

29 Sep 2026

Perioperative Imfinzi plus neoadjuvant enfortumab vedotin granted Priority Review in the US for patients with muscle-invasive bladder cancer

28 Sep 2026

Alexion advances pioneering leadership in gMG care with data at 2026 AANEM Annual Meeting and MGFA Scientific Session

28 Sep 2026

AstraZeneca expands company’s $100m+ commitment to advance youth health equity in more than 60 countries

AstraZeneca expands company’s $100m+ commitment to advance youth health equity in more than 60 countries

28 Sep 2026

Trixeo approved in the EU for the maintenance treatment of asthma

28 Sep 2026

Klygefa (gefurulimab) recommended for approval in the EU by CHMP for the treatment of adults with generalised myasthenia gravis (gMG)

28 Sep 2026

Imfinzi plus Imdelltra demonstrated a statistically significant and highly clinically meaningful improvement in overall survival and progression-free survival in 1st-line extensive-stage small cell lung cancer

09 Sep 2026

Tozorakimab demonstrated statistically significant and highly clinically meaningful reduction in COPD exacerbations in OBERON and TITANIA Phase III trials

09 Sep 2026

Etcamah in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer

09 Sep 2026

Start your free subscription today!

View details about the software product Informachine News Trackers

Latest articles

Lohum starts Zimbabwe lithium operations with first ore shipment

 Lohum starts Zimbabwe lithium operations with first ore shipment

OpenAI deepens Samsung alliance on next-generation AI chips

 OpenAI deepens Samsung alliance on next-generation AI chips

Google commits €13 billion to Finnish AI infrastructure with nuclear deal

 Google commits €13 billion to Finnish AI infrastructure with nuclear deal

Texas audits 474 GW data centre queue as US tackles speculative power demand

 Texas audits 474 GW data centre queue as US tackles speculative power demand

China issues overseas competition guidelines for automakers as exports expand

 China issues overseas competition guidelines for automakers as exports expand

Private investment strengthens as India records 7.8% GDP growth in Q1

 Private investment strengthens as India records 7.8% GDP growth in Q1

Switzerland keeps October 1 transparency register launch despite hack fears

 Switzerland keeps October 1 transparency register launch despite hack fears

US 10-year yield tests 4.75% as hawkish Fed signals lift rate bets

 US 10-year yield tests 4.75% as hawkish Fed signals lift rate bets

EPA weighs refinery waivers of up to 1.8 billion RINs amid farm backlash

 EPA weighs refinery waivers of up to 1.8 billion RINs amid farm backlash